benzoquinoxaline has been researched along with Triple Negative Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, MH; Lin, JH | 1 |
1 other study(ies) available for benzoquinoxaline and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; DNA Damage; DNA Topoisomerases, Type I; Down-Regulation; Drug Design; Female; G-Quadruplexes; Humans; Ligands; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-myc; Quinoxalines; Transplantation, Heterologous; Triple Negative Breast Neoplasms | 2021 |